Examples of using Genentech in English and their translations into Hebrew
{-}
-
Colloquial
-
Ecclesiastic
-
Computer
-
Programming
In late 2005, Genentech announced outcomes of one research study demonstrating improved
Lucentis(ranibizumab), marketed by Genentech, gained FDA approval for the treatment of diabetic macular edema in 2012 and was approved for the treatment of diabetic retinopathy(with or without DME) in April 2017.
Top-line results from one or more of the ongoing solid tumor trials under the Company's collaboration with Genentech, potentially by the end of 2019
recombinant DNA synthesis technology was successfully designed in the 1979 by Genentech and has been used ever since for the synthetic manufacturing of all kinds of complex proteins and protein hormones.
Genentech this week will step up its efforts to keep the drug Avastin available as a treatment for breast cancer,
The British writers noted that Genentech officials followed correct protocol and undertook the expense and research involved with
Genentech announced positive top line results from the Roche-sponsored Phase III Pemphix study evaluating the efficacy
including with Teva and Genentech.
He joined Roche in 2006. From April 2009 to 2010 he was chief executive of the Roche subsidiary Genentech. He rejoined Roche Pharma AG in 2010 as chief operating officer.[8].
not support Avastin's effectiveness, the approval should be retained while Genentech does one more clinical trial.
Paid to Promote Eye Drug, and Prescribing It Widely- When the drug maker Genentech introduced a major product in 2006, it found itself in an awkward position:
Phase 2a COMBAT study, partial results in the Phase 1b/2 pancreatic cancer trial under our collaboration with Genentech, and a potential interim analysis on the Phase 2b BLAST study in AML consolidation therapy," concluded Mr. Serlin.
Genentech Access Solutions.
Genentech, in collaboration with Novartis Ophthalmics,
Genentech, in partnership with Novartis Ophthalmics,
Xolair is being jointly developed by Novartis and Genentech, Inc.
Genentech is the drug company that produces Rituxan(rituximab).
The full press release from Genentech can be found here.
Genentech, in the United States, is a wholly owned member of the Roche Group.
Genentech, in the United States,